Vnzymes Expands into Europe with New Frankfurt Office for Animal Nutrition Innovation
Vnzymes, a European subsidiary of VTR Biotech Group, has marked a significant milestone in its global expansion with the grand opening of its office in Frankfurt. This move underscores the company's commitment to driving innovation in animal nutrition, industrial enzymes, and sustainable agriculture across Europe and beyond.
The new Frankfurt office will serve as the hub for Vnzymes' European operations, supporting research and development, technical services, and local market development tailored to regional needs. Vnzymes' core product portfolio includes xylanase and phytase enzymes, which enhance nutrient digestibility, improve phosphorus utilization, and support intestinal health and growth performance in livestock. The company also offers natural feed additives derived from Macleaya cordata, which boost feed intake, strengthen immunity, enhance antioxidant capacity, and promote sustainable and healthy animal production.
Cindy Chen, CEO of Vnzymes, expressed that the launch of Vnzymes in Europe creates a platform that leverages global expertise while addressing local market requirements in animal nutrition and health. This strategic step is part of VTR Biotech's international growth plan, focusing on accelerating innovation in animal nutrition and health, bio-agriculture, and plant extracts.
The opening of Vnzymes' Frankfurt office signals a significant step in the company's global expansion and commitment to driving innovation in its fields. With its portfolio of enzymes and natural feed additives, Vnzymes is well-positioned to support sustainable and efficient animal production across Europe.
